India  

DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine

IndiaTimes Thursday, 30 July 2020
A CDSCO expert panel has sought clarifications from Serum Institute of India (SII) over its application to the DCGI seeking permission for conducting phase 2 and 3 human clinical trials of the Oxford vaccine candidate for COVID-19, official sources said on Wednesday. On Wednesday evening, SII submitted a revised protocol for conducting the trials to the DCGI.
0
shares
ShareTweetSavePostSend
 
Video Credit: Veuer - Published
News video: Proposed COVID-19 Vaccine Becomes First in U.S. to Reach Phase 3 Test Trials

Proposed COVID-19 Vaccine Becomes First in U.S. to Reach Phase 3 Test Trials 00:57

A proposed coronavirus vaccine becomes the first in the U.S. to start phase three trials. Veuer’s Justin Kircher has the story.

You Might Like


💡 newsR Knowledge: Other News Mentions

Drugs Controller General of India Drugs Controller General of India

Bharat Biotech's Covaxin 77.8 per cent effective in protecting against COVID-19| Oneindia News [Video]

Bharat Biotech's Covaxin 77.8 per cent effective in protecting against COVID-19| Oneindia News

Bharat Biotech's Covaxin is 77.8 per cent effective in protecting against COVID-19 according to data from Phase III trials conducted on 25,800 participants across India. The data was submitted to the DCGI over the weekend. #BharatBiotech #Covaxin #Covid19

Credit: Oneindia    Duration: 02:03Published
Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News [Video]

Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News

Bharat Biotech has submitted Phase 3 clinical trial data for its Covid-19 vaccine, Covaxin, to the Drug Controller General of India (DCGI). The development comes nearly five months after Covaxin was authorised for emergency usage in the country. #Covid19 #BharatBiotech #Covaxin

Credit: Oneindia    Duration: 02:02Published
Gautam Gambhir Foundation guilty of hoarding FabiFlu Covid vaccine: DGCA| Delhi HC | Oneindia News [Video]

Gautam Gambhir Foundation guilty of hoarding FabiFlu Covid vaccine: DGCA| Delhi HC | Oneindia News

The Drugs Controller General of India has found the Gautam Gambhir Foundation guilty of stocking, procuring and distributing Fabiflu medicine in an unaurthorised manner to the COVID-19 patients, the Delhi High Court was informed on Thursday. #GautamGambhir #DCGA #FabiFlu

Credit: Oneindia    Duration: 01:45Published
Pfizer and Moderna vaccines may arrive in India soon| DCGI paves the way | Oneindia News [Video]

Pfizer and Moderna vaccines may arrive in India soon| DCGI paves the way | Oneindia News

In a move to pave the way for the availability of vaccines like Pfizer and Moderna in India, the Drugs Controller General of India (DCGI) has exempted foreign Covid-19 vaccines approved by specific nations or health bodies from post-approval bridging trials in the country. #Pfizer #Moderna #Covid19Vaccine

Credit: Oneindia    Duration: 02:05Published

University of Oxford University of Oxford Collegiate research university in Oxford, England

Oxford vaccine scientists honoured for 'high-stakes endeavour' [Video]

Oxford vaccine scientists honoured for 'high-stakes endeavour'

The pioneering Oxford University scientists who took on the high-stakes challenge of combating Covid-19 have shone a light on the lifesaving work that sees them recognised on the Queen’s Birthday Honours list.Sarah Gilbert, Andrew Pollard, Peter Horby, Martin Landray, Catherine Green, Teresa Lambe and Adrian Hill may not yet be household names, but all played integral roles in the development of a coronavirus vaccine and discovering new drug treatments.

Credit: PA - Press Association STUDIO    Duration: 02:50Published
Age threshold for alternative to AstraZeneca jab raised [Video]

Age threshold for alternative to AstraZeneca jab raised

Under-40s are to be offered an alternative to the Oxford/AstraZeneca Covid-19 vaccine as a precautionary move.

Credit: PA - Press Association STUDIO    Duration: 00:38Published
Under-40s in UK to get alternative Covid jab to AstraZeneca [Video]

Under-40s in UK to get alternative Covid jab to AstraZeneca

Under-40s in the UK will be offered an alternative coronavirus vaccine to the Oxford/AstraZeneca jab. The Joint Committee on Vaccination and Immunisation (JCVI) said there is an "extremely small risk" of people suffering blood clots after having the jab. Report by Thomasl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:00Published
Vaccine production is truly international collaboration in India: EAM [Video]

Vaccine production is truly international collaboration in India: EAM

Union External Affairs Minister, Dr S Jaishankar attended a virtual conversation, called 'Global Dialogue Series' on May 05. He said, "Our vaccine production situation was different from many other countries. On what basis Covishield was being made in India? It's Oxford-AstraZeneca vaccine, you can say it's British-designed product. It was made in India as the vaccine owner saw India as an efficient production venue. Along with that the ability and approval to make in India, came an obligation to supply it to a large part of the world. So, people have to understand, it was not that vaccine production started in India, it was invented by an Indian, owned by an Indian, produced by an Indian." He further said, "It was a truly international collaboration. When there is an international collaboration, if somebody gave you a vaccine to make in India, then you have to do your part, otherwise, it doesn't work. It also came with support from the Covax initiative. So, there was an obligation to support the Covax initiative to give vaccines at a low cost to a number of nations."

Credit: ANI    Duration: 01:57Published
Watch: Congress responds to Adar Poonawalla’s ‘being threatened’ charge [Video]

Watch: Congress responds to Adar Poonawalla’s ‘being threatened’ charge

Maharashtra Congress Chief chief Nana Patole has responded to SII chief Adar Poonawalla’s allegation that he is being threatened. Addressing the media, Patole said that Congress is worried over Poonawalla’s allegations and said that the Congress would take the responsibility of ensuring his security. He further urged Poonawalla to name those politicians who had threatened him over vaccine production. Poonawalla, who flew to London last week, is chief executive officer of the Serum Institute, which is the local maker of the coronavirus vaccine developed by Oxford University and pharmaceuticals company AstraZeneca. Watch the full video for all the details.

Credit: HT Digital Content    Duration: 02:05Published

Serum Institute of India Serum Institute of India Indian biotechnology and biopharmaceuticals company

Serum Institute's COVID-19 vaccine 'Covovax' likely to launch by September

The new vaccine shall be launched under the brand name of Covovax, which SII is manufacturing in partnership with US pharmaceutical firm Novovax.
DNA

SII, Bharat Biotech seek hike in government price for Covid vaccines

Serum Institute of India (SII) and Bharat Biotech (BB) are seeking higher prices for Covid-19 vaccines from the Centre amid concerns that the cost of Covishield..
IndiaTimes

COVID-19: Serum Institute's Novavax vaccine shows 90% overall efficacy

Novavax in collaboration with Indian drug manufacturer Serum Institute of India is manufacturing these vaccines for India and low-income countries.
DNA

Covid-19: Novavax set for India launch with Serum Institute of India as manufacturing partner

The uncertain path to authorisation in the US for Novavax despite passing the efficacy test with an impressive score of 90.4% might see India emerge as a major..
IndiaTimes
Novavax vaccine over 90% effective in U.S. trial [Video]

Novavax vaccine over 90% effective in U.S. trial

Novavax Inc on Monday reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus. Emer McCarthy reports.

Credit: Reuters - Politics    Duration: 01:41Published

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

Nicola Sturgeon delays Scotland unlocking [Video]

Nicola Sturgeon delays Scotland unlocking

First Minister Nicola Sturgeon has delayed the next step in Scotland’s Covid unlocking until July 19th. Report by Buseld. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:27Published
SC approves scheme proposed to calculate the marks for students of Class 12| CBSE| Oneindia News [Video]

SC approves scheme proposed to calculate the marks for students of Class 12| CBSE| Oneindia News

The Supreme Court today approved of the scheme proposed by the CBSE and CISCE to calculate the marks for students of Class 12 this year since their regular exams have been cancelled due to Covid. SC said that There is no reason to interfere with the CBSE and ICSE schemes. #SC #CBSE #Class12th

Credit: Oneindia    Duration: 02:06Published

'Bharat Biotech's Covaxin shows 77.8% efficacy in phase 3 trials'

Bharat Biotech's Covaxin has demonstrated 77.8% efficacy in phase 3 trials, reported ANI quoting sources. The Hyderabad-based firm had earlier submitted the..
IndiaTimes

Related videos from verified sources

Covid update: India on herd immunity; Kolkata extends flight ban till Aug 15 [Video]

Covid update: India on herd immunity; Kolkata extends flight ban till Aug 15

From India stating that herd immunity is not a strategic option yet, to Kolkata extending flight ban, here are the top updates on coronavirus. Health Ministry on Thursday said herd immunity is not a..

Credit: HT Digital Content     Duration: 03:30Published
Watch: Health Ministry gives updates on Covid cases, vaccines & herd immunity [Video]

Watch: Health Ministry gives updates on Covid cases, vaccines & herd immunity

The health ministry in its briefing on Covid-19 situation said that over 1 million people have recovered from Covid infection in the country. Addressing the media, Secretary in the Health Ministry..

Credit: HT Digital Content     Duration: 08:50Published
COVID-19 vaccine: Health Ministry engaging with all stakeholders [Video]

COVID-19 vaccine: Health Ministry engaging with all stakeholders

The Health Ministry has started engaging with COVID-19 vaccine stakeholders within and outside government. "There are multiple stakeholders within and outside government and Ministry of Health has..

Credit: ANI     Duration: 01:33Published

Related news from verified sources

Preparations begin for vaccine trials

Jeevan Rekha Hospital, Belagavi, on Tuesday began preparations for the first phase of trials of Covaxin, the vaccine molecule developed by Hyderabad-b
Hindu Also reported by •IndiaTimes

India's two COVID-19 vaccines in phase 1 and 2 trials: Govt

*New Delhi:* The number of COVID-19 deaths per million population in India continues to be among the lowest in the world, Rajesh Bhushan, Officer on Special Duty...
Mid-Day Also reported by •IndiaTimesHindu

DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine

A CDSCO expert panel has sought clarifications from Serum Institute of India (SII) over its application to the DCGI seeking permission for conducting phase 2 and...
IndiaTimes Also reported by •Hindu